Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2013-04-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Furthermore, it is hypothesised that dual-energy acquisition may improve the accuracy of the assessment of perfusion.
Although initial in-vitro results are encouraging, this technology has not been rigorously assessed with regards to its feasibility and diagnostic quality, limiting its applicability in routine clinical practice. This assessment will require a trial comparing the accuracy of Cardiac GSI CTCA with that of Invasive coronary angiography (ICA) for anatomical assessment of stenosis, Myocardial Perfusion Imaging with Single Photon Emission Computed Tomography (MPI-SPECT) for assessment of perfusion and Cardiac Magnetic Resonance (CMR) for assessment of myocardial scar. We have designed a pilot study in this regard which will help us assess the feasibility of the scan protocol and provide data to power a larger study to assess the diagnostic remit of Cardiac GSI scanning in the assessment of patients with high-risk of significant coronary artery disease and myocardial scar.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dual Energy Cardiac CT Data Collection and Evaluation
NCT05171764
Cardiogoniometry for Detecting Coronary Artery Disease by CT Angiography
NCT02725671
Visual Estimation of Coronary Fractional Flow Reserve From High-definition Computed Tomographic Coronary Angiography
NCT02179957
Relationship Between Coronary CT Angiography Findings and Prognosis Of Patients Undergoing PCI
NCT07051473
Magnetocardiography as a Noninvasive Diagnostic Strategy for Identifying Coronary Allograft Vasculopathy
NCT05751915
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anatomical accuracy Cardiac GSI vs ICA
The identification and quantification of coronary artery stenoses using Cardiac in comparison to ICA.
Cardiac GSI
A novel method of computed tomography scanning (Cardiac Gemstone Spectral Imaging - Cardiac GSI) and image reconstruction (Adaptive Statistical Iterative Reconstruction- ASIR.
Stress perfusion Cardiac GSI vs MPI-SPECT
Assessment of the functional impact of coronary stenoses using Cardiac GSI in comparison to MPI-SPECT
Cardiac GSI
A novel method of computed tomography scanning (Cardiac Gemstone Spectral Imaging - Cardiac GSI) and image reconstruction (Adaptive Statistical Iterative Reconstruction- ASIR.
Delayed enhancement Cardiac GSI vs CMR
Assessment of abnormal myocardial tissue characteristics representing ischaemic or scarred tissue using Cardiac GSI in comparison to CMR.
Cardiac GSI
A novel method of computed tomography scanning (Cardiac Gemstone Spectral Imaging - Cardiac GSI) and image reconstruction (Adaptive Statistical Iterative Reconstruction- ASIR.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac GSI
A novel method of computed tomography scanning (Cardiac Gemstone Spectral Imaging - Cardiac GSI) and image reconstruction (Adaptive Statistical Iterative Reconstruction- ASIR.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients \>50 years of age
* Suspected or known coronary artery disease referred for ICA
Stress perfusion arm
* Patients \>50 years of age
* Suspected or established coronary artery disease referred for MPI-SPECT for assessment of inducible ischaemia
Delayed enhancement arm
* Patients \>50 years of age
* Referred for CMR for assessment of myocardial viability/scar
Exclusion Criteria
* Consent cannot be obtained
* Patient BMI \> 30 kg /m2
* NYHA class III or IV heart failure
* Chronic total occlusion of target epicardial coronary artery
* Urgent revascularisation required
* Allergy to iodinated contrast or previous contrast induced nephropathy
* Intolerance or contraindication to beta-blockers
* Uncontrolled heart rhythm disturbances
* 2nd or 3rd degree atrioventricular block
* Estimated glomerular filtration rate \<30ml/min within two weeks prior to procedure or chronic renal failure on dialysis
* Pregnancy
Stress perfusion arm
* As above, plus:
* Asthma (any) or intolerance to adenosine
Delayed enhancement arm
\- As for Accuracy arm
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Plymouth NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ben Clayton, MBBS
Role: PRINCIPAL_INVESTIGATOR
Plymouth Hospitals NHS Trust (UK)
Gareth Morgan-Hughes, MBBS
Role: PRINCIPAL_INVESTIGATOR
Plymouth Hospitals NHS Trust (UK)
Franchesca Wotton, MBBS
Role: STUDY_DIRECTOR
Plymouth Hospitals NHS Trust (UK)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Plymouth Hospitals NHS Trust
Plymouth, Devon, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13/SW/0065
Identifier Type: OTHER
Identifier Source: secondary_id
13/P/031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.